Ariez Publishing
Dr. Adriaan Vanderstichele discusses the results of the PAOLA-1 study in patients with advanced HRD-positive and BRCA non-mutated ovarian cancer and its clinical implications (Dutch)
00:00 / 17:33
Advertisement